RETRACTED: El-Masry et al. Potential Antitumor Activity of Combined Lycopene and Sorafenib Against Solid Ehrlich Carcinoma via Targeting Autophagy and Apoptosis and Suppressing Proliferation. Pharmaceuticals 2024, 17, 527
Thanaa A. El-Masry, Maysa M. F. El-Nagar, Nageh A. El Mahdy, Fatemah A. Alherz, Reham Taher, Enass Y. Osman · 2025
Read RETRACTED: El-Masry et al. Potential Antitumor Activity of Combined Lycopene and Sorafenib Against Solid Ehrlich Carcinoma via Targeting Autophagy and Apoptosis and Suppressing Proliferation. Pharmaceuticals 2024, 17, 527 by Thanaa A. El-Masry, Maysa M. F. El-Nagar, Nageh A. El Mahdy, Fatemah A. Alherz, Reham Taher, Enass Y. Osman (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12771546.txt.
Description
A peer-reviewed research article from Europe PMC (2025). Autophagy and Apoptosis and Suppressing Proliferation” [1] cited above. Following publication, concerns were brought to the attention of the Editorial Office regarding the integrity of a number of images presented in this publication [1]. Adhering to our standard procedure, an investigation was conducted by the Editorial Office and Editorial Board that identified irregularities and partial duplication in Figures 2–4 presented in this article.
Catalog record
| CREATOR | Thanaa A. El-Masry, Maysa M. F. El-Nagar, Nageh A. El Mahdy, Fatemah A. Alherz, Reham Taher, Enass Y. Osman |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |